跳至主要内容
临床试验/JPRN-UMIN000037891
JPRN-UMIN000037891已完成未知

A Prospective Epidemiology Study to Estimate the Attack Rate of Respiratory Syncytial Virus Infection in Adults Aged 65 Years and Older in Japan - A Prospective Epidemiology Study to Estimate the Attack Rate of Respiratory Syncytial Virus Infection in Adults Aged 65 Years and Older in Japan

Janssen Pharmaceutical K.K. R&D Clinical Science div. Infectious disease & Vaccine Clinical Development Dept.0 个研究点目标入组 1,000 人开始时间: 2019年9月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,000

研究概览

简要总结

Respiratory syncytial virus was reported as a major pathogen for respiratory infection and represents a significant burden in the Japanese elderly population.

研究设计

研究类型
Observational

入排标准

年龄范围
65years-old 至 999years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • -Participants received any experimental antiviral drugs or vaccines against respiratory syncytial virus (RSV) within 6 months prior to the signing Informed Consent Form (ICFs) - Participants who have acute respiratory disease (ARD) at the time of ICF and Week 0 (Baseline) at the discretion of the investigator - Participants with life expectancy less than 1 year - Participants unwilling to undergo nasopharyngeal swab procedures or with any physical abnormality which limits the ability to collect regular nasopharyngeal specimens - Participant who is not able to comply with study-related procedures,due to their mental status or severe clinical condition, based on clinical judgement of the investigator

研究者

发起方
Janssen Pharmaceutical K.K. R&D Clinical Science div. Infectious disease & Vaccine Clinical Development Dept.

相似试验